Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Branaplam (LMI 070) 是一种高效、选择性和口服活性的小分子 SMN2 剪接调节剂,对 SMN 的 EC50为 20 nM。它可提高全长 SMN 蛋白并延长其生存期,也抑制 hERG,IC50为 6.3 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 442 | 现货 | ||
2 mg | ¥ 638 | 现货 | ||
5 mg | ¥ 997 | 现货 | ||
10 mg | ¥ 1,800 | 现货 | ||
25 mg | ¥ 2,920 | 现货 | ||
50 mg | ¥ 3,970 | 现货 | ||
100 mg | ¥ 5,730 | 现货 | ||
500 mg | ¥ 11,500 | 现货 | ||
1 mL * 5 mM (in DMSO) | ¥ 1,130 | 现货 |
产品描述 | Branaplam (LMI 070) is a highly potent, selective and orally active small molecule SMN2 splicing modulator. |
靶点活性 | SMN:20 nM (IC50), ERG (human):6.3 μM (EC50) |
体内活性 | To evaluate the efficacy of NVS-SM1, we used the SMNΔ7 mouse model, which displays a severe phenotype. In the specific colony used for this study, death typically occurs before postnatal day 15. We were pleased to observe that, in addition to a dose-dependent elevation of SMN protein in the brain, oral administration of NVS-SM1 improved body weight and extended lifespan, with 50% of the animals in the 1 mg per kg body weight group and 62% of animals in the 3 mg per kg body weight group showing increased survival. |
别名 | LMI 070, NVS-SM1 |
分子量 | 393.48 |
分子式 | C22H27N5O2 |
CAS No. | 1562338-42-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.8 mg/mL (9.6 mM), Sonication and heating are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5414 mL | 12.7071 mL | 25.4143 mL | 63.5356 mL |
5 mM | 0.5083 mL | 2.5414 mL | 5.0829 mL | 12.7071 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Branaplam 1562338-42-4 Cell Cycle/Checkpoint DNA Damage/DNA Repair Membrane transporter/Ion channel Others Potassium Channel DNA/RNA Synthesis SMN2 SMA inhibit SMN Inhibitor hERG atrophy neuron-2 motor KcsA gene orally splicing LMI070 LMI 070 LMI-070 NVS-SM1 spinal survival muscular inhibitor